PMID: 589308Dec 10, 1977

Acute leukaemia after busulphan

British Medical Journal
H StottD A Galton

Abstract

During a double-blind study of two years' cytotoxic chemotherapy with busulphan or cyclophosphamide in patients who had had resection of carcinoma of the bronchus the long-term effects of these two drugs were also studied. Four of the 243 patients treated with busulphan developed leukaemia compared with none of the 234 treated with cyclophosphamide and none of the 249 on placebo. None of these four patients received radiotherapy or other cytotoxic chemotherapy before leukaemia was diagnosed, and all four were among the 19 patients who developed pancytopenia while taking busulphan, five to eight years before leukaemia became clinically apparent. These findings suggest that busulphan is leukaemogenic, though its mode of action is uncertain.

References

Oct 9, 1976·Lancet·M M Roberts
Mar 1, 1973·Cancer·H L DavisB C Korbitz
Apr 1, 1974·Cancer·R K KarchmerG G Caldwell
Jan 1, 1972·JAMA : the Journal of the American Medical Association·R A KaslowJ L Glass
Nov 1, 1967·The American Journal of Medicine·T Cohen, W P Creger
Nov 19, 1970·The New England Journal of Medicine·R A KyleE D Bayrd
Jun 26, 1971·British Medical Journal·I W Delamore, C G Geary
Sep 1, 1961·Archives of Environmental Health·E P CRONKITE
Sep 7, 1963·JAMA : the Journal of the American Medical Association·R L DEGOWIN
Mar 21, 1964·British Medical Journal·H J WOODLIFF, L DOUGAN
Oct 22, 1964·The New England Journal of Medicine·E C VIGLIANI, G SAITA
Nov 26, 1960·British Medical Journal·R H Bean

Citations

Nov 15, 2002·International Journal of Hematology·Ruben A Mesa
Jan 1, 1987·Pharmacology & Therapeutics·P B Farmer
Jul 1, 1986·Mutation Research·J B Bishop, J S Wassom
Apr 1, 1988·European Journal of Cancer & Clinical Oncology·J M KaldorK Hemminki
Mar 3, 1983·The New England Journal of Medicine·G J RustinK D Bagshawe
Nov 3, 1983·The New England Journal of Medicine·J D BoiceJ F Fraumeni
Aug 3, 2012·Journal of Hematology & Oncology·Jasleen RandhawaSrdan Verstovsek
Jan 1, 1993·Cancer Biotherapy·M R Chasen, G Falkson
Jan 1, 1995·Leukemia & Lymphoma·C AulW Schneider
May 30, 2001·Leukemia & Lymphoma·G LeoneL Pagano
Feb 19, 2002·British Journal of Haematology·M C PettiF Mandelli
Feb 11, 2016·World Journal of Clinical Oncology·Clarke Brian Blackadar
May 5, 2000·The Cochrane Database of Systematic Reviews·Non-small Cell Lung Cancer Collaborative Group
Dec 1, 1979·Cancer·P H EllimsB S Faragher
Mar 19, 2020·The New England Journal of Medicine·Elisa Rumi, Mario Cazzola
Jan 1, 1988·European Journal of Haematology. Supplementum·J Pedersen-Bjergaard, P Philip
Jun 1, 1982·British Journal of Haematology·G J den OttolanderP J Spaander
Sep 1, 1990·American Journal of Hematology·S StortiB Bizzi
Mar 19, 2020·The New England Journal of Medicine·Ayalew Tefferi, Animesh Pardanani

Related Concepts

Acute Disease
Bronchial Neoplasms
n-Butane-1,3-di(methylsulfonate)
Cyclophosphamide, (S)-Isomer
Dose-Response Relationship, Drug
Leukemia
Neoplasms, Multiple Primary
Pancytopenia

Related Feeds

Carcinoma, Bronchogenic

Bronchogenic Carcinoma is a malignant lung cancer arising in the epithelium of the bronchus or bronchiole. Discover the latest research on Bronchogenic Carcinoma here.